Contact this trialFirst, we need to learn more about you.
Factor IX + Emicizumab for Hemophilia A
Recruiting2 awardsPhase < 1
New Orleans, Louisiana
This trial is testing different blood-clotting substances in patients with severe hemophilia A who are already on Emicizumab. The goal is to see which substance helps their blood clot better. Researchers will measure the effectiveness of these substances in helping the blood to form clots.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.